Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,824 | 71,239 | 85,947 | 0 | 0 |
| Marketable Securities | 35,000 | 29 | 29 | 0 | 0 |
| Receivables | 338 | 265 | 387 | 0 | 0 |
| Other current assets | 357 | 264 | 290 | 0 | 0 |
| TOTAL | $151,551 | $77,279 | $88,051 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 43 | 27 | 30 | N/A | N/A |
| Other Non-Current Assets | 243 | 282 | 0 | 0 | 0 |
| TOTAL | $286 | $309 | $30 | $N/A | $N/A |
| Total Assets | $151,837 | $77,588 | $88,081 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,288 | 3,906 | 4,477 | 0 | 0 |
| TOTAL | $6,463 | $4,152 | $4,533 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 61 | 138,862 | 138,758 | 0 | 0 |
| TOTAL | $61 | $138,862 | $138,758 | $N/A | $N/A |
| Total Liabilities | $6,524 | $143,014 | $143,291 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,491 | 24,491 | N/A | N/A | N/A |
| Common Shares | 226,211 | 2,090 | 2,039 | 0 | 0 |
| Retained earnings | -82,380 | -68,722 | -58,270 | 0 | 0 |
| Other shareholders' equity | -1,634 | -1,634 | -1,634 | 0 | 0 |
| TOTAL | $145,313 | $-65,426 | $-55,210 | $0 | $0 |
| Total Liabilities And Equity | $151,837 | $77,588 | $88,081 | $0 | $0 |